Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKK Topical Preparation for Radiation-Induced Skin Injury
NCT07635277Phase 1Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of akkermansia muciniphila in radiation-induced skin injury (RSI), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of Grade >=2 Acute Radiation Dermatitis. Started Jun 2026; status: recruiting.
02
Drugs
akkermansia muciniphila
03
Conditions
radiation-induced skin injury (RSI)
Beyond the preview
Go deeper on NCT07635277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635277.